Clinical Trial Update: Prevention of Recurrent Preterm Delivery by a Natural Progesterone Agent [NA]

View source ↗

Summary

A clinical trial evaluating a natural progesterone agent to prevent recurrent preterm delivery has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preterm Birth

Drugs mentioned

• Progesterone (natural progesterone agent) (Progesterone)

Snippet

Sponsor: The Baruch Padeh Medical Center, Poriya | Conditions: Pregnancy, Premature Birth | NA | Status: WITHDRAWN